Bank of America’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Bank of America’s Portfolio PRTK Stock Details PRTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-15,000	Closed	-$289K	–	7247
2017 Q1	$289K	Buy	+15,000	New	+$236K	﹤0.01%	5150
2014 Q4	–	Sell	-125	Closed	-$3K	–	8050
2014 Q3	$3K	Sell	125 -83	-40%	-$2.17K	﹤0.01%	7712
2014 Q2	$5K	Buy	208 +125	+151%	+$4.08K	﹤0.01%	7664
2014 Q1	$3K	Hold	83	–	–	﹤0.01%	7482
2013 Q4	$3K	Sell	83 -42	-34%	-$1.78K	﹤0.01%	7585
2013 Q3	$5K	Buy	+125	New	+$4.47K	﹤0.01%	7403

Bank of America's PRTK Position: Q3 2023 in Review

Bank of America sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q3 2023, closing a stake of 34,480 shares — an estimated $76.2K sold.

Bank of America first reported a position in PRTK in Q2 2013 and held it in 41 quarters. The position peaked at $1.22M in Q1 2021. 0 funds tracked by Wall St. Rank hold PRTK as of Q3 2023.

Bank of America reported no remaining Paratek Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
Bank of America sold 34,480 Paratek Pharmaceuticals, Inc. shares in Q3 2023, an estimated $76.2K.
Bank of America first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2013 and held it in 41 quarters.
Bank of America's Paratek Pharmaceuticals, Inc. position peaked at $1.22M in Q1 2021.
0 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2023.

Based on Bank of America's 13F filing for Q3 2023, filed 14 Nov 2023.